Chimera Partners

Shoplazza is a shopping cart commerce technology company established in 2017, focused on providing an all-in-one eCommerce platform for businesses of all sizes. The platform enables merchants to easily start, market, and manage their online stores through a single integrated back-end system. It emphasizes reliability, security, and adaptability, allowing merchants to create a headless commerce experience. Shoplazza also has a North America-based Direct-to-Customer branding incubation team that supports merchants in building memorable and distinctive brands while fostering direct relationships with buyers. The company's advanced data analytical capabilities enhance its offerings, ensuring that merchants can effectively grow their businesses independently. With its global strategy department located in Toronto, Shoplazza aims to empower merchants worldwide.

CMR Surgical, established in 2014 and headquartered in Cambridge, UK, specializes in designing and manufacturing medical devices for minimal access surgery. The company's primary product is the Versius surgical robotic system, which facilitates laparoscopic surgery by providing surgeons with 3D high-definition imagery and feedback. CMR Surgical aims to make minimal access surgery universally accessible and affordable by expanding the range of procedures that can be performed using its robotic systems.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

GoReport is a Belfast-based company that specializes in survey management solutions for the property sector. Founded in 2011, it offers a platform that allows surveyors to conduct various types of surveys and generate reports more efficiently. The platform enables users to capture relevant survey data directly on an iPad through an intuitive interface that includes standard and custom phrases, automated voice-to-text capabilities, and pick lists. By streamlining the reporting process, GoReport significantly reduces the time required to complete surveys and create branded reports, helping businesses enhance their operational efficiency.

Fuel3D is a company that specializes in advanced 3D scanning technology, offering an affordable handheld scanner designed for high-quality shape and color capture across various creative applications. The scanner utilizes a unique combination of pre-calibrated stereo cameras and photometric imaging to produce detailed 3D images quickly, making it accessible to independent game developers, designers, and artists. Originally developed for the medical imaging sector at Oxford University by a team of engineers and scientists, Fuel3D's technology has been adapted for broader markets, aiming to democratize point-and-shoot 3D imaging. The company, now led by CEO Stuart Mead, focuses on providing rapid and accurate analysis of organic subjects, serving clients in fields ranging from art and animation to gaming and retail.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

Fuel3D is a company that specializes in advanced 3D scanning technology, offering an affordable handheld scanner designed for high-quality shape and color capture across various creative applications. The scanner utilizes a unique combination of pre-calibrated stereo cameras and photometric imaging to produce detailed 3D images quickly, making it accessible to independent game developers, designers, and artists. Originally developed for the medical imaging sector at Oxford University by a team of engineers and scientists, Fuel3D's technology has been adapted for broader markets, aiming to democratize point-and-shoot 3D imaging. The company, now led by CEO Stuart Mead, focuses on providing rapid and accurate analysis of organic subjects, serving clients in fields ranging from art and animation to gaming and retail.